Among these mutations, a significant proportion of epidermal growth factor receptor (EGFR) mutations are detected in 10%-15% of advanced NSCLC in Western populations and 40%-50% in Asians (3, 4). This evidence concerns the gene EGFR and non-small cell lung carcinoma.